Luteolin offers novel therapeutic regimen in rotenone-induced Parkinson disease via modulation of TNF-α/FXMRP/serotonin/tyrosine hydroxylase signaling pathway. NJPS [Internet]. 31 grudzień 2025 [cytowane 31 maj 2026];40(2):251-62. Dostępne na: http://www.ojshostng.com/index.php/njphysiologicalsciences/article/view/4001